Zoladex and Prandin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zoladex (goserelin acetate) and Prandin (repaglinide). Common drug interactions include abdominal pain among females and death among males.
The phase IV clinical study analyzes what interactions people have when they take Zoladex and Prandin. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Zoladex?
Zoladex has active ingredients of goserelin acetate. It is often used in prostate cancer. eHealthMe is studying from 13,870 Zoladex users. Check the latest studies of Zoladex.
What is Prandin?
Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,680 Prandin users. Check the latest studies of Prandin.
15 people who take Zoladex and Prandin together, and have interactions are studied.
What are the common drug interactions of Zoladex and Prandin, by gender? *:
female:
- Abdominal pain
- Arthropathy
- Ataxia (loss of full control of bodily movements)
- Atelectasis (partial or complete collapse of the lung)
- Back pain
- Bone loss
- Cardiomegaly (increased size of heart than normal)
- Cellulitis (infection under the skin)
- Chemical poisoning
- Coccydynia (pain in the coccyx or tailbone area)
male:
- Death
What are the common drug interactions of Zoladex and Prandin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Abdominal pain
- Arthropathy
- Ataxia (loss of full control of bodily movements)
- Atelectasis (partial or complete collapse of the lung)
- Back pain
- Bone loss
- Cardiomegaly (increased size of heart than normal)
- Cellulitis (infection under the skin)
- Chemical poisoning
- Coccydynia (pain in the coccyx or tailbone area)
50-59:
n/a
60+:
- Death
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 14 people, 93.33%
- High Blood Pressure: 14 people, 93.33%
- Depression: 14 people, 93.33%
- Breast Cancer: 14 people, 93.33%
- Bone Pain: 14 people, 93.33%
- Breast Cancer Metastatic: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Zoladex and Prandin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Zoladex and Prandin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zoladex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Prandin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoladex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Prandin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on goserelin acetate and repaglinide (the active ingredients of Zoladex and Prandin, respectively), and Zoladex and Prandin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Delatestryl cause Abdominal Pain? - 2 seconds ago
- Intertrigo and drugs of ingredients of hydrocortisone - 2 seconds ago
- Could Lyrica cause Malignant Melanoma In Situ? - 4 seconds ago
- Drug interactions of Ranexa and Exforge - 8 seconds ago
- Drug interactions of Naprosyn and Ziac - 32 seconds ago
- Lactobacillus and Thrombocytopenia for Men aged 60+ - 37 seconds ago
- Lactobacillus and Low Platelet Count for Men aged 60+ - 37 seconds ago
- Lactobacillus and Platelet Count Decreased for Men aged 60+ - 37 seconds ago
- Could Synthroid cause Hypersplenism? - 37 seconds ago
- Lactobacillus and Thin Blood for Men aged 60+ - 38 seconds ago